M&A Deal Summary |
|
|---|---|
| Date | 2013-03-18 |
| Target | Complete Genomics |
| Sector | Life Science |
| Buyer(s) | BGI-Shenzhen |
| Deal Type | Add-on Acquisition |
| Deal Value | 118M USD |
| Advisor(s) | Jefferies (Financial) Latham & Watkins (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
BGI includes both private non-profit genomic research institutes and sequencing application commercial units that provide comprehensive sequencing and bioinformatics services for medical, agricultural and environmental applications. Our commercial activities help our customers achieve their research goals by delivering rapid, high-quality results using a broad array of cost-effective, cutting-edge technologies. Our customers also benefit from our scientific expertise and research experience that have generated over 250 publications in top-tier journals such as Nature and Science. BGI is recognized globally as an innovator for conducting international collaborative projects with leading research institutions to better mankind and our world.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector (Life Science) | 1 of 1 |
| Type (Add-on Acquisition) | 1 of 1 |
| State (California) | 1 of 1 |
| Country (United States) | 1 of 1 |
| Year (2013) | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
